Article
Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.
Biochimica et biophysica acta - 1 Mar 2016
Galán-Díez Marta, Isa Adiba, Ponzetti Marco, Nielsen Morten Frost, Kassem Moustapha, Kousteni Stavroula
Abstract excerpt
Osteoblasts are emerging regulators of myeloid malignancies since genetic alterations in them, such as constitutive activation of β-catenin, instigate their appearance. The LDL receptor-related protein 5 (LRP5), initially proposed to be a co-receptor for Wnt proteins, in fact favors bone formation by suppressing gut-serotonin synthesis. This function of Lrp5 occurring in the gut is independent of β-catenin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
